Table 1

Characteristics of all Surveillance, Epidemiology and End Results (SEER) participants, by their stage of pancreas cancer

Stage IA
N=409
Stage IB
N=757
Stage IIA
N=1907
Stage IIB
N=5192
Stage III
N=1305
Stage IV
N=3561
Age at diagnosis—median (range)66 (30, 88)66 (31, 89)68 (31, 93)66 (30, 95)67 (31, 94)67 (30, 95)
Age at diagnosis—mean (SD)64.8 (11.1)64.9 (12)67.1 (10.6)65.7 (10.9)66.1 (11.5)66.1 (12)
Race—number (%)
 Black37 (9)88 (12)177 (9)462 (9)177 (14)494 (14)
 Other29 (7)69 (9)162 (8)331 (6)116 (9)271 (8)
 White343 (84)600 (79)1568 (82)4399 (85)1012 (78)2796 (79)
Sex—number (%)
 Female201 (49)395 (52)947 (50)2537 (49)654 (50)1646 (46)
 Male208 (51)362 (48)960 (50)2655 (51)651 (50)1915 (54)
Location—number (%)
 Body61 (15)124 (16)147 (8)272 (5)234 (18)702 (20)
 Head248 (61)441 (58)1469 (77)4421 (85)979 (75)1944 (55)
 Tail100 (24)192 (25)291 (15)499 (10)92 (7)915 (26)
Grade—no. (%)
 G1174 (43)208 (27)254 (13)564 (11)197 (15)415 (12)
 G2172 (42)359 (47)982 (51)2582 (50)517 (40)1182 (33)
 G356 (14)178 (24)629 (33)1966 (38)563 (43)1826 (51)
 G47 (2)12 (2)42 (2)80 (2)28 (2)138 (4)
Size (cm)—median (range)1.5 (0.5, 2)3.2 (2.1, 15)3 (0.7, 14)3.3 (0.5, 15)4 (0.5, 14)4 (0.5, 15)
Size (cm)—number (%)
 ≤2 cm409 (100)0 (0)345 (18)735 (14)93 (7)234 (7)
 2–4 cm0 (0)535 (71)1095 (57)3124 (60)594 (46)1554 (44)
 >4 cm0 (0)222 (29)467 (24)1333 (26)618 (47)1773 (50)
T stage—number (%)
 T1409 (100)0 (0)0 (0)172 (3)0 (0)111 (3)
 T20 (0)757 (100)0 (0)624 (12)0 (0)1070 (30)
 T30 (0)0 (0)1907 (100)4396 (85)0 (0)1514 (43)
 T40 (0)0 (0)0 (0)0 (0)1305 (100)866 (24)
N stage—number (%)
 N0409 (100)757 (100)1907 (100)0 (0)751 (58)1956 (55)
 N10 (0)0 (0)0 (0)5192 (100)554 (42)1605 (45)